Clinical and laboratory findings characterizing the need for systemic corticosteroids and nonsteroidal systemic therapies and the predicted outcomes in cutaneous polyarteritis nodosa: a single-centre retrospective analysis

Author:

Tanaka Ryo12ORCID,Tanese Keiji1,Ito Yoshihiro1,Takeuchi Sakiko1,Morimoto Ari1,Sujino Kazuyo1,Amagai Masayuki1,Tanikawa Akiko1

Affiliation:

1. Department of Dermatology, Keio University School of Medicine , Shinjuku-ku, Tokyo , Japan

2. Division of Dermatology, Department of Surgical Subspecialties, National Center for Child Health and Development , Setagaya-ku, Tokyo , Japan

Abstract

Abstract Background Cutaneous polyarteritis nodosa (cPN) is a necrotizing arteritis of medium-sized vessels limited to the skin. Because of its rarity and the diversity of its clinical manifestations, there is no consensus treatment. Moreover, there are no established indicators that predict disease severity or its outcome. Objectives To investigate clinicolaboratory features that predict patients requiring systemic therapy, including corticosteroids, to control disease activity. Methods Thirty-six patients with cPN who had not received systemic corticosteroids at their initial visit were retrospectively analysed by correlating the treatment and its response with clinicolaboratory findings. Results The major medications administered were antiplatelet agents [64% (23/36)], vasodilators [39% (14/36)] and prednisolone (PSL) [36% (13/36)]. In total, 23 patients achieved remission without PSL, 5 were managed with compression therapy alone or even observation and 18 received antiplatelet monotherapy or combined with vasodilator/dapsone whereas 13 required PSL. Of the 13 who required PSL, 10 achieved remission with PSL monotherapy or PSL and single/multiple medications and 3 with PSL and multiple drugs then failed to achieve remission and underwent limb amputation. There were more skin ulcers and an elevated peripheral white blood cell (WBC) count and erythrocyte sedimentation rate (ESR) before corticosteroid induction in patients requiring PSL. Three patients with treatment failure had a markedly elevated ESR (> 50 mm h–1). Conclusions More than half of patients with cPN can achieve remission without corticosteroids. An elevated WBC, an elevated ESR and the presence of skin ulcers predict the need for PSL. A high ESR before corticosteroid induction predicts treatment resistance, even with PSL.

Funder

Advantest Corporation

Publisher

Oxford University Press (OUP)

Reference18 articles.

1. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides;Jennette;Clin Exp Nephrol,2013

2. Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda;Karadag;Clin Exp Rheumatol,2018

3. Survey of Japanese dermatological vasculitis specialists on cases of cutaneous arteritis (cutaneous polyarteritis nodosa);Ikeda;J Dermatol,2020

4. Clinical approach to diagnosis and therapy of polyarteritis nodosa;Hocevar;Curr Rheumatol Rep,2021

5. Rituximab in refractory cutaneous polyarteritis;Krishnan;Int J Rheum Dis,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3